-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Inotersen Sodium in Amyloid Cardiomyopathy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Inotersen Sodium in Amyloid Cardiomyopathy Drug Details: Inotersen sodium (Tegsedi) is a methoxyethyl phosphorothioate antisense...
-
Product Insights
Electrophysiology Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Electrophysiology Devices Pipeline Market Report Overview Electrophysiology equipment analyzes the electrical activity of the heart. The equipment is used with cardiac catheters and sophisticated computers to generate electrocardiogram (EKG) tracings and electrical measurements with exquisite precision from within the heart chambers. RF generators may be used in conjunction with electrophysiology equipment to treat the abnormal impulse generating areas in the heart. The Electrophysiology Devices pipeline market research report provides comprehensive information about the Electrophysiology Devices pipeline products with comparative analysis...
-
Product Insights
Cardiac Ablation Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Cardiac Ablation Devices Pipeline Products Market Report Overview Cardiac Ablation Devices are devices that use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm. The Cardiac Ablation Devices pipeline market research report provides comprehensive information about the Cardiac Ablation Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Cardiovascular Surgery Devices Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiovascular Surgery Devices Pipeline Market Report Overview Cardiovascular surgery devices include devices used in cardiovascular surgeries such as coronary artery bypass surgery. The cardiovascular surgery devices pipeline market research report provides comprehensive information about the cardiovascular surgery devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the report provides information about various pipeline products and their estimated approval dates.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Amidosulfonate silver lactone B
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Amidosulfonate silver lactone B Drug Details Amidosulfonate silver lactone B is under development for...
-
Product Insights
Net Present Value Model: Tegsedi
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Tegsedi Drug Details Inotersen sodium (Tegsedi)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – flecainide acetate
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry flecainide acetate Drug Details Flecainide acetate (Inrhythm) is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – inotersen sodium
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry inotersen sodium Drug Details Inotersen sodium (Tegsedi) is a methoxyethyl phosphorothioate antisense oligonucleotide. It...
-
Product Insights
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Leukotriene A4 hydrolase (LTA4H) is an enzyme which converts leukotriene A4 to leukotriene B4 and acts as an aminopeptidase. LTB4 is a potent lipid chemoattractant involved in inflammation, immune responses, host defense against infection and PAF-induced shock. The LTA4H - Drugs In Development research report provides a comprehensive overview on the therapeutics under development for LTA4H, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers...
-
Sector Analysis
Brazil Meat Market Analysis and Forecasts, 2015-2025 – Analyzing Product Categories and Segments, Distribution Channel, Competitive Landscape, Packaging and Consumer Segmentation
The meat market in Brazil was valued at $32.0 billion in 2020 and is forecasted to register a growth of more than 6% during the period of 2021-2025. Per capita consumption of meat was higher in Brazil than at both the global and regional levels in 2020. Fresh meat (counter) was the largest category in 2020, followed by chilled raw packaged meat - whole cuts, chilled raw packaged meat - processed, cooked meats - packaged, frozen meat, cooked meats –...